Rapidly progressive dementia: Causes found in a greek tertiary referral center in athens

Alzheimer Disease and Associated Disorders

Volumn 23, Issue 4, 2009, Pages 337-346

  Papageorgiou, Sokratis G ^a   Kontaxis, Theodoros ^a   Bonakis, Anastasios ^a   Karahalios, Georgios ^a   Kalfakis, Nikolaos ^a   Vassilopoulos, Demetrios ^a  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

Author keywords

Dementia; Rapidly progressive dementias; Secondary dementias; Spongiform encephalopathy; Treatable dementias

Indexed keywords

ADULT; ALZHEIMER DISEASE; ARTICLE; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL EVALUATION; CREUTZFELDT JAKOB DISEASE; DEGENERATIVE DISEASE; DEMENTIA; DISEASE COURSE; FEMALE; FRONTOTEMPORAL DEMENTIA; GLIOBLASTOMA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; MULTIPLE SCLEROSIS; NEUROSYPHILIS; NORMOTENSIVE HYDROCEPHALUS; ONSET AGE; PARANEOPLASTIC NEUROPATHY; PRIORITY JOURNAL; Q FEVER; SARCOIDOSIS; SCLERODERMA; SYSTEMIC LUPUS ERYTHEMATOSUS; TERTIARY HEALTH CARE; VASCULITIS;

ACADEMIC MEDICAL CENTERS; ADULT; AGED; AGED, 80 AND OVER; DEMENTIA; DISEASE PROGRESSION; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; TIME FACTORS;

EID: 75949105682     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0b013e31819e099b     Document Type: Article

References (48)

1. Spiegel J, Hellwig D, Becker G, et al. Progressive dementia caused by Hashimoto's encephalopathy-report of two cases. Eur J Neurol. 2004;11:711-713.
2. Kothbauer-Margreiter I, Sturzenegger M, Komor J, et al. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol. 1996;243:585-593.
3. Carlson BA. Rapidly progressive dementia caused by non- 'enhancing primary lymphoma of the central nervous system. AJNR Am J Neuroradiol. 1996;17:1695-1697.
4. DeAngelis LM. Cerebral lymphoma presenting as a nonenhancing lesion on computed tomographic/magnetic resonance scan. Ann Neurol. 1993;33:308-311.
5. Bornke C, Heye N, Buttner T. Rapidly progressive dementia. Lancet. 1999;353:1150.
6. Moore PM. Neurological manifestation of vasculitis: update on immunopathogenic mechanisms and clinical features. Ann Neurol. 1995;37 (suppl 1):S131-S141.
7. Shiga Y, Wakabayashi H, Miyazawa K, et al. 14-3-3 protein levels and isoform patterns in the cerebrospinal fluid of Creutzfeldt-Jakob disease patients in the progressive and terminal stages. J Clin Neurosci. 2006;13:661-665.
8. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease. Ann Neurol. 1998;43:32-40.
9. Huang N, Marie SK, Livramento JA, et al. 14-3-3 protein in the CSF of patients with rapidly progressive dementia. Neurology. 2003;61:354-357.
10. Shiga Y, Miyazawa K, Sato S, et al. Diffusion-weighted MRI abnormalities as an early diagnostic marker for Creutzfeldt- Jakob disease. Neurology. 2004;63:443-449.
11. Sanchez-Valle R, Saiz A, Graus F. 14-3-3 protein isoforms and atypical patterns of the 14-3-3 assay in the diagnosis of Creutzfeldt-Jakob disease. Neurosci Lett. 2002;320:69-72.
12. Mendonca RA, Martins G, Lugokenski R, et al. Subacute spongiform encephalopathies. Top Magn Reson Imaging. 2005;16:213-219.
13. Tschampa HJ, Neumann M, Zerr I, et al. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry. 2001;71:33-39.
14. Reinwald S, Westner IM, Niedermaier N. Rapidly progressive Alzheimer's disease mimicking Creutzfeldt-Jakob disease. J Neurol. 2004;251:1020-1022.
15. Caselli RJ, Couce ME, Osborne D, et al. From slowly progressive amnesic syndrome to rapidly progressive Alzheimer disease. Alzheimer Dis Assoc Disord. 1998;12:251-253.
16. Catani M, Piccirilli M, Geloso MC, et al. Rapidly progressive aphasic dementia with motor neuron disease: a distinctive clinical entity. Dement Geriatr Cogn Disord. 2004;17:21-28.
17. Tsuchiya K, Ozawa E, Fukushima J, et al. Rapidly progressive aphasia and motor neuron disease: a clinical, radiological, and pathological study of an autopsy case with circumscribed lobar atrophy. Acta Neuropathol (Berlin). 2000;99:81-87.
18. Armstrong TP, Hansen LA, Salmon DP, et al. Rapidly progressive dementia in a patient with the Lewy body variant of Alzheimer's disease. Neurology. 1991;41:1178-1180.
19. Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol. 1994;35:513-529.
20. Masters CL, Harris JO, Gajdusek DC, et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol. 1979; 5:177-188.
21. Van Everbroeck B, Dobbeleir I, De Waele M, et al. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients. J Neurol. 2004;251:298-304.
22. Knopman DS, DeKosky ST, Cummings JL, et al. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2001;56:1143-1153.
23. Waldemar G, Dubois B, Emre M, et al. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol. 2007;14:1-26.
24. Folstein MF, Folstein SE, McHugh PR. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
25. Dubois B, Slachevsky A, Litvan I, et al. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55:1621-1626.
26. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules [comments]. Neurology. 1993; 43:2412-2414.
27. Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44:2308-2314.
28. Kertesz A, Davidson W, Fox H. Frontal Behavioral Inventory: diagnostic criteria for frontal lobe dementia. Can J Neurol Sci. 1997;24:29-36.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders DSM-IV Fourth Edition-Text Revision. Washington, DC: American Psychiatric Association; 2000.
30. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDSADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
31. Roman GC, Tatemichi TK, Erkinjuntti T, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43: 250-260.
32. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB International Workshop. Neurology. 1996;47:1113-1124.
33. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51:1546-1554.
34. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele- Richardson-Olszewski syndrome): report of the NINDS-SPSP International Workshop. Neurology. 1996;47:1-9.
35. World Health Organization (WHO). Global surveillance, diagnosis and therapy of human transmissible spongiform encephalopathies: report of a WHO consultation. Geneva 1998. WHO/EMC/ZDI/98.9.
36. Quinn N. Multiple system atrophy-the nature of the beast. J Neurol Neurosurg Psychiatry. 1989;52 (supp l):78-89.
37. Litvan I, Agid Y, Goetz C, et al. Accuracy of the clinical diagnosis of corticobasal degeneration: a clinicopathologic study. Neurology. 1997;48:119-125. (Pubitemid 27039529)
38. Poser S, Mollenhauer B, Kraubeta A, et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain. 1999; 122(Pt 12):2345-2351.
39. Geschwind MD, Martindale J, Miller D, et al. Challenging the clinical utility of the 14-3-3 protein for the diagnosis of sporadic Creutzfeldt-Jakob disease. Arch Neurol. 2003; 60:813-816.
40. Geschwind MD, Shu H, Haman A, et al. Rapidly progressive dementia. Ann Neurol. 2008;64:97-108.
41. Rivas E, Sanchez-Herrero J, Alonso M, et al. Miliary brain metastases presenting as rapidly progressive dementia. Neuropathology. 2005;25:153-158.
42. Ikeda M, Hokoishi K, Maki N, et al. Increased prevalence of vascular dementia in Japan: a community-based epidemiological study. Neurology. 2001;57:839-844.
43. Vraamark Elberling T, Stokholm J, Hogh P, et al. Diagnostic profile of young and middle-aged memory clinic patients. Neurology. 2002;59:1259-1262.
44. Gislason TB, Sjogren M, Larsson L, et al. The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds. J Neurol Neurosurg Psychiatry. 2003;74:867-871.
45. Harvey RJ, Roques P, Fox NC, et al. Non-Alzheimer dementias in young patients. Br J Psychiatry. 1996; 168:384-385.
46. Snowden JS, Neary D, Mann DM. Frontotemporal dementia. Br J Psychiatry. 2002;180:140-143.
47. Rusina R, Bourdain F, Matej R. Multiple system atrophy and Alzheimer's disease: a case report of a rare association of two neuro-degenerative disorders. Rev Neurol (Paris). 2007; 163:1239-1241.
48. Wenning GK, Tison F, Ben Shlomo Y, et al. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997;12:133-147.